These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22740380)

  • 1. Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study.
    van der Heijde D; Deodhar A; Inman RD; Braun J; Hsu B; Mack M
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1919-22. PubMed ID: 22740380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions.
    van der Heijde D; Landewé R; Feldtkeller E
    Ann Rheum Dis; 2008 Apr; 67(4):489-93. PubMed ID: 17728332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial.
    Deodhar A; Braun J; Inman RD; Mack M; Parasuraman S; Buchanan J; Hsu B; Gathany T; van der Heijde D
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1266-71. PubMed ID: 20506403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial.
    Bao C; Huang F; Khan MA; Fei K; Wu Z; Han C; Hsia EC
    Rheumatology (Oxford); 2014 Sep; 53(9):1654-63. PubMed ID: 24729398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal mobility in the cervical and lumbar spine correlates with magnetic resonance imaging findings for inflammatory and structural changes in patients with active ankylosing spondylitis.
    Baraliakos X; Hermann KA; Xu S; Hsia EC; Braun J
    Clin Exp Rheumatol; 2020; 38(3):467-471. PubMed ID: 32242806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
    Inman RD; Baraliakos X; Hermann KA; Braun J; Deodhar A; van der Heijde D; Xu S; Hsu B
    Arthritis Res Ther; 2016 Dec; 18(1):304. PubMed ID: 28031053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE).
    van der Heijde D; Braun J; Deodhar A; Inman RD; Xu S; Mack ME; Hsu B
    Rheumatology (Oxford); 2013 Feb; 52(2):321-5. PubMed ID: 23024015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.
    Inman RD; Davis JC; Heijde Dv; Diekman L; Sieper J; Kim SI; Mack M; Han J; Visvanathan S; Xu Z; Hsu B; Beutler A; Braun J
    Arthritis Rheum; 2008 Nov; 58(11):3402-12. PubMed ID: 18975305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year follow-up of two exercise interventions for the management of patients with ankylosing spondylitis: a randomized controlled trial.
    Fernández-de-Las-Peñas C; Alonso-Blanco C; Alguacil-Diego IM; Miangolarra-Page JC
    Am J Phys Med Rehabil; 2006 Jul; 85(7):559-67. PubMed ID: 16788386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial.
    van der Heijde D; Deodhar A; Braun J; Mack M; Hsu B; Gathany TA; Inman RD; Han C;
    J Rheumatol; 2014 Jun; 41(6):1095-103. PubMed ID: 24737912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study.
    Braun J; Deodhar A; Inman RD; van der Heijde D; Mack M; Xu S; Hsu B
    Ann Rheum Dis; 2012 May; 71(5):661-7. PubMed ID: 22012970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study.
    Deodhar A; Braun J; Inman RD; van der Heijde D; Zhou Y; Xu S; Han C; Hsu B
    Ann Rheum Dis; 2015 Apr; 74(4):757-61. PubMed ID: 25387477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis: the correlation between a new metrology score and radiology.
    Kennedy LG; Jenkinson TR; Mallorie PA; Whitelock HC; Garrett SL; Calin A
    Br J Rheumatol; 1995 Aug; 34(8):767-70. PubMed ID: 7551663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The safety and efficacy of golimumab in treatment of 25 patients with active ankylosing spondylitis].
    Ma H; Sun F; Zhang YM; Zhang H; Zhu J; Deng XH; Zhang JL; Huang F
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):935-939. PubMed ID: 29202535
    [No Abstract]   [Full Text] [Related]  

  • 17. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.
    Kay J; Matteson EL; Dasgupta B; Nash P; Durez P; Hall S; Hsia EC; Han J; Wagner C; Xu Z; Visvanathan S; Rahman MU
    Arthritis Rheum; 2008 Apr; 58(4):964-75. PubMed ID: 18383539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
    Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH
    Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Oldfield V; Plosker GL
    BioDrugs; 2009; 23(2):125-35. PubMed ID: 19489653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.
    Jenkinson TR; Mallorie PA; Whitelock HC; Kennedy LG; Garrett SL; Calin A
    J Rheumatol; 1994 Sep; 21(9):1694-8. PubMed ID: 7799351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.